A prospective study to assess the effectiveness of lignocaine versus normal saline in the reduction of pain associated with dressing removal in finger tip injuries

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-005591-32-GB

Enrollment

Registered

2006-04-10

Start date

2006-05-05

Completion date

Unknown

Last updated

2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Finger tip injuries

Interventions

Trade Name: Lidocaine 1% Injection Product Name: LIGNOCAINE Product Code: lignocaine Pharmaceutical Form: Injection* INN or Proposed INN

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have sustained a nailbed injury, partial or full amputation of the finger tip Patients over the age of 16 years Patients willing to participate in study Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Patients who have previous injury or surgery to the presenting digit Patients within any other concommitant trial involving analgesics Patients allergic to lignocaine Patients who are unable to give consent

Design outcomes

Primary

Measure	Time frame
Main Objective: To assess the effectiveness of lignocaine versus normal saline in the reduction of pain associated with dressing removal in finger tip injuries;Secondary Objective: ;Primary end point(s): To reduce the pain associated with the removal of dressings from finger tip injuries	—

Countries

United Kingdom

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026